Literature DB >> 20960160

Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma.

Kathryn S King1, Nissar A Darmani, Marybeth S Hughes, Karen T Adams, Karel Pacak.   

Abstract

A cohort of nine patients, mostly young adults, presented with a new sign/symptom of pheochromocytoma/paraganglioma: exercise-induced nausea and vomiting. The aims of this article are to introduce this sign/symptom and offer a possible hypothesis for the observation. Following a 2000 report from a paraganglioma patient experiencing exercise-induced nausea and vomiting, we began asking patients about instances of nausea and vomiting with exercise. A total of nine patients, 4.4% of our pheochromocytoma/paraganglioma population, presented with reports of exercise-induced nausea and vomiting, initially with moderate-to-intense levels of exercise, at the first presentation of their disease. All of these patients reported a cessation of exercise-induced nausea and vomiting following the removal of their primary tumor. Two patients with metastatic disease to the lungs reported a recurrence of exercise-induced nausea and vomiting. The majority of patients studied were young adults with mean onset age of 19.4 years (range of 9-51 years) and the mean age of diagnosis being 24.1 years (range of 11-53 years). Exercise-induced nausea and vomiting should be considered a sign/symptom of pheochromocytoma/paraganglioma and should be addressed in the clinical evaluation of these patients, especially in young adults. Whether exercise-induced elevated catecholamine levels could account for the induced nausea and vomiting via activation of adrenergic receptors in the area postrema remains to be established.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960160      PMCID: PMC4130359          DOI: 10.1007/s12020-010-9319-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  16 in total

1.  The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).

Authors:  N A Darmani; W Zhao; B Ahmad
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

Review 2.  The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

Authors:  Gregory A Kaltsas; Dimitris Papadogias; Ashley B Grossman
Journal:  Front Horm Res       Date:  2004       Impact factor: 2.606

3.  Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.

Authors:  Henri J L M Timmers; Anna Kozupa; Graeme Eisenhofer; Margarita Raygada; Karen T Adams; Daniel Solis; Jacques W M Lenders; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

4.  Comparison of morphine alone with morphine plus clonidine for postoperative patient-controlled analgesia.

Authors:  S A Jeffs; J E Hall; S Morris
Journal:  Br J Anaesth       Date:  2002-09       Impact factor: 9.166

Review 5.  New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines.

Authors:  Jacques W M Lenders; Karel Pacak; Graeme Eisenhofer
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

Review 6.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

7.  Genetic testing in pheochromocytoma or functional paraganglioma.

Authors:  Laurence Amar; Jérôme Bertherat; Eric Baudin; Christiane Ajzenberg; Brigitte Bressac-de Paillerets; Olivier Chabre; Bernard Chamontin; Brigitte Delemer; Sophie Giraud; Arnaud Murat; Patricia Niccoli-Sire; Stéphane Richard; Vincent Rohmer; Jean-Louis Sadoul; Laurence Strompf; Martin Schlumberger; Xavier Bertagna; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

8.  Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.

Authors:  Graeme Eisenhofer; David S Goldstein; McClellan M Walther; Peter Friberg; Jacques W M Lenders; Harry R Keiser; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  Oral clonidine premedication does not reduce postoperative vomiting in children undergoing strabismus surgery.

Authors:  N Gulhas; A Turkoz; M Durmus; T Togal; E Gedik; M O Ersoy
Journal:  Acta Anaesthesiol Scand       Date:  2003-01       Impact factor: 2.105

10.  The analgesic effect of epidural clonidine after spinal surgery: a randomized placebo-controlled trial.

Authors:  Andrew D Farmery; James Wilson-MacDonald
Journal:  Anesth Analg       Date:  2009-02       Impact factor: 5.108

View more
  6 in total

1.  Cyclic vomiting associated with excessive dopamine in Riley-day syndrome.

Authors:  Lucy J Norcliffe-Kaufmann; Felicia B Axelrod; Horacio Kaufmann
Journal:  J Clin Gastroenterol       Date:  2013-02       Impact factor: 3.062

Review 2.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

3.  Light-intensity Activity-related Nausea: An Unusual Presentation of Pheochromocytoma.

Authors:  Sakditad Saowapa; Parin Rattananon; Chutintorn Sriphrapradang
Journal:  Cureus       Date:  2019-10-17

4.  Exercise-induced vomiting.

Authors:  Paweł Samborski; Anna Chmielarz-Czarnocińska; Marian Grzymisławski
Journal:  Prz Gastroenterol       Date:  2013-12-30

5.  Paradoxical hypertension.

Authors:  Sreenivasa Rao Sudulagunta; Monica Kumbhat; Mahesh Babu Sodalagunta; Shiva Kumar Bangalore Raja
Journal:  Oxf Med Case Reports       Date:  2018-07-25

6.  Effects of Aerobic and Resistance Exercises on Physical Symptoms in Cancer Patients: A Meta-analysis.

Authors:  Jiro Nakano; Kaori Hashizume; Takuya Fukushima; Kazumi Ueno; Emi Matsuura; Yuta Ikio; Shun Ishii; Satoru Morishita; Koji Tanaka; Yoko Kusuba
Journal:  Integr Cancer Ther       Date:  2018-10-23       Impact factor: 3.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.